If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
377.50    2.50 (0.67%)
Bid:
374.50
Ask:
376.50
Spread: 2.00 (0.534%)
Market Cap: £1.93b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

8 Jun 2017 14:31

RNS Number : 5776H
Caledonia Investments PLC
08 June 2017
 

Caledonia Investments plc

Director/PDMR Shareholding Notification

 

Caledonia Investments plc ("Caledonia") has been notified pursuant to the requirements of the EU Market Abuse Regulations of the following transactions involving three of its directors, Jamie Cayzer-Colvin, Stephen King and William Wyatt as detailed below.

 

On 6 June 2017, ordinary 5p shares were transferred to the above-named directors under Caledonia's 2011 Deferred Bonus Plan ("Deferred Bonus Plan") and 2011 Performance Share Scheme ("Performance Share Scheme"), at nil cost. On the same date, Mr Cayzer-Colvin exercised options under Caledonia's 2005 Executive Share Option Scheme ("Executive Share Option Scheme") at an exercise price of 1446p. All resulting shares were sourced from the Caledonia Investments plc Employee Share Trust and subsequently sold at 2910p per share on the same date.

 

Deferred Bonus Plan

No of shares transferred under the Deferred Bonus Plan at £nil

 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

 

11,302

0.02

11,302

SA King

13,365

0.02

13,365

WP Wyatt

 

18,837

0.03

18,837

 

Performance Share Scheme

No of shares transferred under the Performance Share Scheme at £nil

 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

 

19,749

0.04

19,749

SA King

11,194

0.02

11,194

WP Wyatt

 

15,776

0.03

15,776

 

 

Executive Share Option Scheme

No of options exercised under the Executive Share Option Scheme at 1446p

 

% of issued capital

No of shares sold

JMB Cayzer-Colvin

12,707

0.02

12,707

 

Further information required by the EU Market Abuse Regulations in relation to these transactions is set out in the appendix below.

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc

+ 44 20 7802 8080

8 June 2017

 

APPENDIX 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Caledonia Investments plc

b)

 

LEI

 

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Exercise of options with an exercise price of £14.46

3. Call of Deferred Bonus Plan ("DBP") awards

4. Sale of all shares

 

 

c)

 

 

 

Price(s) and volume(s)

 

 

1. Exercise of PSS awards

 

2. Exercise of options

 

3. Call of DBP awards

 

4. Sale of shares

 

 

 

Price(s)

 

Volume(s)

£0.00

 

19,749

 

£14.46

12,707

£0.00

11,302

£29.10

43,758

d)

 

Aggregated information

 

- Aggregated volume

 

 

 

 

 

- Price

 

 

 

 

Exercise of PSS awards, exercise of options with an exercise price of £14.46 and call of DBP awards: 43,758

 

Sale of shares: 43,758

 

Exercise of PSS awards (£nil), exercise of options with an exercise price of £14.46 (£14.46) and call of DBP awards (£nil): weighted average price £4.20

 

Sale of shares: £29.10

 

e)

 

Date of the transaction

 

 

6 June 2017

f)

 

Place of the transaction

 

 

Exercise of PSS awards, options with an exercise price of £14.46 and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stephen Anthony King

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Caledonia Investments plc

b)

 

LEI

 

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

 

 

Price(s) and volume(s)

 

 

 

1. Exercise of PSS awards

 

2. Call of DBP awards

 

3. Sale of shares

 

 

 

Price(s)

 

Volume(s)

£0.00

 

11,194

 

£0.00

13,365

£29.10

24,559

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

 

 

- Price

 

 

 

 

Exercise of PSS awards and call of DBP awards: 24,559

 

Sale of shares: 24,559

 

Exercise of PSS awards and call of deferred shares: £nil

 

Sale of shares: £29.10

 

e)

 

Date of the transaction

 

 

6 June 2017

f)

 

Place of the transaction

 

 

Exercise of PSS awards and call of DBP awards - outside a trading venue

 

Sale of shares - London Stock Exchange XLON

 

 

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

William Penfold Wyatt

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Caledonia Investments plc

b)

 

LEI

 

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS awards

 

2. Call of DBP awards

 

3. Sale of shares

 

 

 

Price(s)

 

Volume(s)

£0.00

 

15,776

 

£0.00

18,837

£29.10

34,613

 

 

 

 

 

d)

 

 

 

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

Exercise of PSS awards and call of DBP awards: 34,613

 

Sale of shares: 34,613

 

 

Exercise of PSS awards and call of deferred shares: £nil

 

Sale of shares: £29.10

 

e)

 

Date of the transaction

 

 

6 June 2017

f)

 

Place of the transaction

 

 

Exercise of PSS awards and call of DBP awards - outside a trading venue

 

Sale of shares - London Stock Exchange XLON

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSUFDAFWSEEM
Date   Source Headline
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)
20th Apr 20239:40 amRNSAcquisition
12th Apr 202310:42 amRNSResponse to press speculation
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20229:22 amRNSNet Asset Value(s)
22nd Nov 20227:00 amRNSDirectorate Change
22nd Nov 20227:00 amRNSHalf-year Report
7th Nov 202210:49 amRNSNet Asset Value(s)
7th Oct 20227:00 amRNSUnaudited net asset value and portfolio update
30th Sep 20224:21 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:51 pmRNSDirector/PDMR Shareholding
6th Sep 202210:17 amRNSNet Asset Value(s)
23rd Aug 20225:21 pmRNSDirector/PDMR Shareholding
15th Aug 20222:21 pmRNSDirector Declaration
4th Aug 202212:41 pmRNSNet Asset Value(s)
27th Jul 20224:47 pmRNSResult of AGM
19th Jul 20224:59 pmRNSDirector Declaration
7th Jul 20227:00 amRNSUnaudited net asset value and portfolio update
23rd Jun 20224:00 pmRNSAnnual Financial Report
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
16th Jun 20224:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.